Performance of Three Commercial Molecular Diagnostic Assays for the Simultaneous Detection of Mycoplasma genitalium and Macrolide Resistance - INRAE - Institut national de recherche pour l’agriculture, l’alimentation et l’environnement Access content directly
Journal Articles Journal of Clinical Microbiology Year : 2021

Performance of Three Commercial Molecular Diagnostic Assays for the Simultaneous Detection of Mycoplasma genitalium and Macrolide Resistance

Abstract

The increasing frequency of macrolide resistance is an emerging issue in the treatment of Mycoplasma genitalium infection. Because evaluation of new commercial kits detecting M. genitalium and macrolide resistance is needed, we evaluated the performance and handling characteristics of the Allplex MG & AziR (Seegene), the Macrolide-R/MG ELITe MGB (ELITechGroup), and the ResistancePlus MG FleXible (SpeeDx-Cepheid) kits in comparison with those of an in-house real-time PCR and 23S rRNA gene sequencing used as the reference.

Dates and versions

hal-04123293 , version 1 (09-06-2023)

Identifiers

Cite

Chloé Le Roy, Cécile Bébéar, Sabine Pereyre. Performance of Three Commercial Molecular Diagnostic Assays for the Simultaneous Detection of Mycoplasma genitalium and Macrolide Resistance. Journal of Clinical Microbiology, 2021, 59 (6), ⟨10.1128/JCM.00020-21⟩. ⟨hal-04123293⟩

Collections

INRA INRAE
5 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More